International Clinical Trial: Phase 1 Study Involving SAB01 and Healthy Participants

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815561) titled 'Phase 1 Study Involving SAB01 and Healthy Participants' on Sept. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Santa Ana Bio

Condition: Healthy Adult Participants

Intervention: Drug: Subcutaneous (SC) single dose of SAB01 Drug: Intravenous (IV) infusion of SAB01 Drug: Placebo SC

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: August 31, 2026

Target Sample Size: 88

Countries of Recruitm...